Search
Descriptor English: Clopidogrel
Descriptor Spanish: Clopidogrel
Descriptor Portuguese: Clopidogrel
Descriptor French: Clopidogrel
Entry term(s): Clopidogrel Besilate
Clopidogrel Besylate
Clopidogrel Bisulfate
Clopidogrel Hydrochloride
Clopidogrel Mepha
Clopidogrel Napadisilate
Clopidogrel Sandoz
Clopidogrel, (+)(S)-isomer
Clopidogrel-Mepha
Iscover
PCR 4099
PCR-4099
Plavix
SC 25989C
SC 25990C
SR 25989
Tree number(s): D02.886.778.823.500.500
D03.383.725.849.500.500
D03.383.903.830.500.500
D03.633.100.928.500.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077144
Scope note: A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.
Annotation:
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Registry Number: A74586SNO7
CAS Type 1 Name: Methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate
Public MeSH Note: 2019; CLOPIDOGREL was indexed under TICLOPIDINE 1988-2018
History Note: 2019 (1988)
DeCS ID: 57516
Unique ID: D000077144
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/07/09
Clopidogrel - Preferred
Concept UI M0155432
Scope note A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.
Preferred term Clopidogrel
SC 25989C - Narrower
Concept UI M0155428
Preferred term SC 25989C
SC 25990C - Narrower
Concept UI M0155429
Preferred term SC 25990C
SR 25989 - Narrower
Concept UI M0155430
Preferred term SR 25989
Clopidogrel-Mepha - Narrower
Concept UI M000624947
Preferred term Clopidogrel-Mepha
Entry term(s) Clopidogrel Mepha
Clopidogrel Sandoz - Narrower
Concept UI M000624946
Preferred term Clopidogrel Sandoz
Iscover - Narrower
Concept UI M0446644
Preferred term Iscover
Clopidogrel Napadisilate - Narrower
Concept UI M0568441
Preferred term Clopidogrel Napadisilate
Clopidogrel Hydrochloride - Narrower
Concept UI M0584825
Preferred term Clopidogrel Hydrochloride
PCR 4099 - Narrower
Concept UI M0155425
Preferred term PCR 4099
Entry term(s) PCR-4099
Clopidogrel Besylate - Narrower
Concept UI M0584824
Preferred term Clopidogrel Besylate
Entry term(s) Clopidogrel Besilate
Clopidogrel, (+)(S)-isomer - Narrower
Concept UI M0323598
Preferred term Clopidogrel, (+)(S)-isomer
Plavix - Narrower
Concept UI M0155427
Preferred term Plavix
Clopidogrel Bisulfate - Narrower
Concept UI M0424331
Preferred term Clopidogrel Bisulfate



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey